Telesis Bio, Inc. (TBIO)

USD 0.49

(-7.55%)

Gross Profit Summary of Telesis Bio, Inc.

Telesis Bio, Inc.'s latest annual gross profit in 2023 was 16.95 Million USD , down -17.61% from previous year.
Telesis Bio, Inc.'s latest quarterly gross profit in 2024 Q1 was 271 Thousand USD , down -93.38% from previous quarter.
Telesis Bio, Inc. reported a annual gross profit of 15.59 Million USD in annual gross profit 2022, up 262.76% from previous year.
Telesis Bio, Inc. reported a annual gross profit of 4.29 Million USD in annual gross profit 2021, up 18.59% from previous year.
Telesis Bio, Inc. reported a quarterly gross profit of -1.6 Million USD for 2024 Q2, down -394.83% from previous quarter.
Telesis Bio, Inc. reported a quarterly gross profit of 2.99 Million USD for 2023 Q3, down -47.36% from previous quarter.

Annual Gross Profit Chart of Telesis Bio, Inc. (2023 - 2016)

Historical Annual Gross Profit of Telesis Bio, Inc. (2023 - 2016)

Year	Gross Profit	Gross Profit Growth
2023	16.95 Million USD	-17.61%
2022	15.59 Million USD	262.76%
2021	4.29 Million USD	18.59%
2020	3.62 Million USD	188.76%
2019	-4.08 Million USD	-387.61%
2018	1.42 Million USD	0.0%
2017	- USD	0.0%
2016	- USD	0.0%

Year	Gross Profit	Gross Profit Growth
2024 Q1	271 Thousand USD	-93.38%
2024 Q2	-1.6 Million USD	-394.83%
2023 Q3	2.99 Million USD	-47.36%
2023 Q2	5.69 Million USD	62.15%
2023 Q4	4.09 Million USD	36.67%
2023 FY	12.84 Million USD	-17.61%
2023 Q1	3.51 Million USD	-45.53%
2022 FY	15.59 Million USD	262.76%
2022 Q1	2.77 Million USD	214.97%
2022 Q4	6.44 Million USD	76.17%
2022 Q3	3.65 Million USD	34.92%
2022 Q2	2.71 Million USD	-2.38%
2021 FY	4.29 Million USD	18.59%
2021 Q1	1.3 Million USD	41.68%
2021 Q2	953 Thousand USD	-26.8%
2021 Q4	882 Thousand USD	-24.1%
2021 Q3	1.16 Million USD	21.93%
2020 Q1	813 Thousand USD	-79.1%
2020 Q2	997 Thousand USD	22.63%
2020 Q3	896 Thousand USD	-10.13%
2020 Q4	919 Thousand USD	2.57%
2020 FY	3.62 Million USD	188.76%
2019 Q4	3.89 Million USD	207.27%
2019 FY	-4.08 Million USD	-387.61%
2019 Q3	1.26 Million USD	7.84%
2019 Q2	1.17 Million USD	-20.35%
2019 Q1	1.47 Million USD	24.7%
2018 Q1	- USD	0.0%
2018 Q2	- USD	0.0%
2018 Q3	238 Thousand USD	0.0%
2018 Q4	1.18 Million USD	396.64%
2018 FY	1.42 Million USD	0.0%
2017 FY	- USD	0.0%
2017 Q1	- USD	0.0%
2017 Q2	- USD	0.0%
2017 Q3	- USD	0.0%
2017 Q4	- USD	0.0%
2016 FY	- USD	0.0%

Peer Gross Profit Comparison of Telesis Bio, Inc.

Name	Gross Profit	Gross Profit Difference
Acutus Medical, Inc.	-3.13 Million USD	640.325%
Biotricity, Inc.	8.35 Million USD	-102.841%
Cell MedX Corp.	- USD	-Infinity%
Dynatronics Corporation	7.63 Million USD	-122.005%
Nemaura Medical Inc.	-1.47 Million USD	1248.069%
PetVivo Holdings, Inc.	739.52 Thousand USD	-2192.009%
RetinalGenix Technologies Inc.	-100.00 USD	16950100.0%
Sonendo, Inc.	10.72 Million USD	-58.086%
Talis Biomedical Corporation	371 Thousand USD	-4468.733%
Viveve Medical, Inc.	620 Thousand USD	-2633.871%